I think you are spot on. Personally I am a bit surprised that we ran up this hard on information released that we sort of were aware of, but I am mot complaining To me it is clear that it is all about the market cap of our company. This is slowly correcting mostly driven by the US which is awakening. I have noticed other companies in the same space as us with inferior compounds, with market caps between US $450M - US 900M. I am looking forward when we release good data from any of the other trials. We just have to be patient. DYOR
KZA Price at posting:
$1.75 Sentiment: Hold Disclosure: Held